Pathophysiology of peritoneal transport

被引:9
|
作者
Twardowski, Zbylut J. [1 ]
机构
[1] Univ Missouri, Dialysis Clin Inc, Columbia, MO 65201 USA
来源
关键词
D O I
10.1159/000093443
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The peritoneal membrane has the surface area similar to the body surface area. It consists of mesothelial cells, interstitium, connective tissue fibers, blood vessels, and lymphatics. Solutes of various sizes traverse the peritoneal membrane through at least three various pores: 'large' pores located in the venular interendothelial gaps, small 'paracellular' pores, and ultrasmall, 'transcellular' pores or aquaporins localized in peritoneal capillaries and mesothelial cells. High molecular weight solutes are mass-transfer limited; thus, their clearances do not increase significantly with high dialysate flow. Clearances of small molecular weight solutes are dialysate flow limited. Ultrafiltration is proportional to the hydrostatic and osmotic transmembrane pressures. The peritoneum offers greater resistance to accompanying solutes than to water (solute sieving), so that the concentration of solutes in the ultrafiltrate is less than in plasma water. Sodium sieving leads to hypertension, which is frequently observed in patients treated with short-dwell or continuous flow peritoneal dialysis. Peritoneal equilibration test is the most commonly used test to characterize peritoneal function and select the most suitable dialysis technique for a patient. Long-term peritoneal dialysis is associated with progressive loss of ultrafiltration capability due to structural and functional alterations in the membrane mostly as the consequence of exposure to glucose degradation products or advanced glycation end products generated during the sterilization process. Copyright (c) 2006 S, Karger AG, Basel.
引用
收藏
页码:13 / 19
页数:7
相关论文
共 50 条
  • [21] The effect of ligustrazine on peritoneal transport in peritoneal dialysis
    Zhonghua Zhu
    Weiyi Peng
    Yumei Wang
    Hongyan Zhu
    Xiao Yang
    Anguo Deng
    Current Medical Science, 2002, 22 (4) : 334 - 336
  • [22] Changes in the peritoneal interstitium and their effect on peritoneal transport
    Flessner, MF
    PERITONEAL DIALYSIS INTERNATIONAL, 1999, 19 : S77 - S82
  • [23] Pathophysiology of reverse cholesterol transport
    Calabresi, L
    CHEMISTRY AND PHYSICS OF LIPIDS, 2005, 136 (02) : 89 - 90
  • [24] Peritoneal transport testing
    La Milia, Vincenzo
    JOURNAL OF NEPHROLOGY, 2010, 23 (06) : 633 - 647
  • [25] Quantification of peritoneal transport
    Yamashita, Akihiro C.
    PERITONEAL DIALYSIS INTERNATIONAL, 2008, 28 : S139 - S143
  • [26] Peritoneal transport and ultrafiltration
    不详
    NEPHROLOGY, 2005, 10 : S104 - S107
  • [27] PATHOPHYSIOLOGY OF LIPID TRANSPORT DISORDERS
    LEVY, RI
    POSTGRADUATE MEDICAL JOURNAL, 1975, 51 : 16 - 26
  • [28] BIOCOMPATIBILITY AND PERITONEAL TRANSPORT
    Krediet, Raymond T.
    PERITONEAL DIALYSIS INTERNATIONAL, 2009, 29 (02): : 147 - 149
  • [29] Peritoneal Transport and Physiology
    Taskapan, Hulya
    TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, 2007, 16 : 2 - 7
  • [30] PERITONEAL TRANSPORT OF CEFONICID
    MORSE, GD
    LANE, T
    NAIRN, DK
    DETERDING, J
    CURRY, J
    GAL, P
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (02) : 292 - 294